Akero Therapeutics, Inc. Derivative Liability, Noncurrent
Akero Therapeutics, Inc. had Derivative Liability, Noncurrent of $400.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2025-11-07
- 2025-06-30: Derivative Liability, Noncurrent $400.00K.
- 2025-03-31: Derivative Liability, Noncurrent $296.00K.
- 2024-12-31: Derivative Liability, Noncurrent $194.00K.
- 2024-09-30: Derivative Liability, Noncurrent $203.00K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $296.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $194.00K 10-Q · filed 2025-11-07 |
| 2024-09-30 | $203.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $164.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $178.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $54.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $93.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $85.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $162.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $305.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $70.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $41.00K 10-Q · filed 2022-08-05 |